Trial Profile
PTH(1-34) for the primary prevention of post-surgical hypocalcemia: the THYPOS trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2024
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Hypocalcaemia; Hypoparathyroidism
- Focus Therapeutic Use
- Acronyms THYPOS
- 01 Nov 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
- 14 Apr 2016 New trial record
- 12 Apr 2016 Status changed from active, no longer recruiting to completed.